학술논문
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
Document Type
Article
Author
Granit, V.; Benatar, M.; Kurtoglu, M.; Miljković, M.D.; Jewell, C.M.; Singer, M.S.; Kalayoglu, M.V.; Chahin, N.; Sahagian, G.; Feinberg, M.H.; Slansky, A.; Vu, T.; Howard, J.F.; Mozaffar, T.; Slansky, A.D.; Pereira, D.; Steele, J.; Paredes, M.E.; Benjamin, C.; Komanduri, K.; Habib, A.A.; Fong, J.K.; De La Cruz, L.; Dimitrova, D.; Chopra, M.; Holley, K.; DeMaria, G.; Tenorio, A.; Requena, N.; Brooks, B.M.; Suresh, N.; Farias, J.; Ngo Casi, M.; Chowdhury, A.; Kamboh, H.; Stewart, C.A.; Tosun, M.; Shang, Y.; Duverney, M.T.; Kireeva, M.; English, E.; Jewell, C.
Source
In: The Lancet Neurology . (The Lancet Neurology, July 2023, 22(7):578-590)
Subject
Language
English
ISSN
14744465
14744422
14744422